Biological network background
Open Source Bioinformatics

Cytoscape
Consortium

Promoting the development and distribution of open source bioinformatic software related to biological networks — empowering researchers worldwide.

Our Impact

Empowering Global
Network Biology Research

The Cytoscape Consortium provides researchers and institutions with the tools, resources, and community support needed to advance biological network analysis. From desktop applications to web libraries, we build the infrastructure for modern bioinformatics.

Read our mission
15,000+
Active Researchers Worldwide
300+
Community-Built Apps
50+
Contributing Institutions
20+
Years of Innovation
Our Software

Open Source Solutions

Powerful, community-driven tools for biological network visualization and analysis.

Cytoscape Desktop

The flagship desktop application for visualizing and analyzing complex biological networks with hundreds of plugin apps.

Learn More

Cytoscape.js

A fully-featured graph library written in pure JavaScript for the web. Integrates seamlessly with modern frameworks.

Learn More

py4cytoscape

Python library for communicating with Cytoscape Desktop, enabling automation of network analysis workflows.

Learn More
Research collaboration

Ready to Explore the Network?

Join thousands of researchers using Cytoscape tools to discover new insights in biological data.

Latest Updates

News & Announcements

Cytoscape 3.10.3 Now Available
Release

Cytoscape 3.10.3 Now Available

The latest update brings improved performance for large-scale networks and new KEGG pathway integration features.

March 5, 2026Read More
Cytoscape Workshop at ISMB 2026
Event

Cytoscape Workshop at ISMB 2026

Join our hands-on workshop at the Intelligent Systems for Molecular Biology conference this July in Montreal.

February 18, 2026Read More
New Study Uses Cytoscape for Cancer Network Analysis
Publication

New Study Uses Cytoscape for Cancer Network Analysis

Researchers at UCSD published findings using Cytoscape to map protein interactions in triple-negative breast cancer.

January 30, 2026Read More